|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 387.75 INR | +0.17% |
|
-3.71% | +24.92% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 365M 319M 294M 271M 511M 522M 3.51B 1.38B 17.19B 1.37B 1.34B 59.19B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 392M 343M 317M 292M 550M 562M 3.78B 1.49B 18.51B 1.47B 1.44B 63.73B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
23.47% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | +0.17% | ||
| 1 week | -3.71% | ||
| Current month | -6.01% | ||
| 1 month | +3.14% | ||
| 3 months | -9.62% | ||
| 6 months | +16.41% | ||
| Current year | +24.92% |
| 1 week | 380.8 |  | 411.3 |
| 1 month | 372.45 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 108.1 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 29/08/1990 | |
| Director of Finance/CFO | - | 12/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 29/08/1990 | |
| Director/Board Member | 37 | 04/06/2020 | |
| Director/Board Member | 48 | 28/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.17% | -3.71% | +56.41% | +280.15% | 377M | |
| -0.90% | -0.15% | +13.46% | +79.34% | 48.15B | |
| -0.23% | -1.65% | +65.14% | +115.81% | 35.59B | |
| -0.76% | -1.44% | -4.30% | +37.38% | 11.9B | |
| -0.88% | -0.62% | +16.38% | +89.65% | 11.85B | |
| +0.19% | +2.87% | +34.92% | +127.54% | 9.31B | |
| -0.75% | -0.91% | +18.26% | +37.23% | 6.91B | |
| -9.93% | +0.35% | -29.90% | +14.89% | 6.13B | |
| +3.37% | -0.10% | +49.31% | -4.38% | 7.02B | |
| -2.25% | -2.08% | +0.40% | +218.27% | 6.55B | |
| Average | -1.20% | -0.31% | +22.01% | +99.59% | 14.38B | |
| Weighted average by Cap. | -0.88% | -0.43% | +26.06% | +86.87% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 73.65M 64.36M 59.39M 54.75M 103M 105M 710M 279M 3.47B 277M 271M 11.96B | 7.83B 81.28M 71.03M 65.55M 60.42M 114M 116M 783M 308M 3.83B 305M 299M 13.2B |
| Net income | 498M 5.17M 4.52M 4.17M 3.85M 7.25M 7.41M 49.87M 19.61M 244M 19.43M 19M 840M | 691M 7.18M 6.27M 5.79M 5.34M 10.06M 10.28M 69.2M 27.22M 339M 26.96M 26.37M 1.17B |
| Net Debt | 2.45B 25.41M 22.2M 20.49M 18.88M 35.59M 36.38M 245M 96.31M 1.2B 95.41M 93.32M 4.12B | 2.69B 27.96M 24.43M 22.55M 20.78M 39.17M 40.04M 270M 106M 1.32B 105M 103M 4.54B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | ₹387.75 | +0.17% | 119,883 |
| 16/07/26 | ₹387.10 | -1.36% | 139,223 |
| 15/07/26 | ₹392.45 | -1.70% | 128,764 |
| 14/07/26 | ₹399.25 | -0.14% | 411,138 |
| 13/07/26 | ₹399.80 | -0.72% | 564,457 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
